Rifampicin Alleviates Atopic Dermatitis-Like Response in vivo and in vitro |
Kim, Seung Hyun
(Institute of Chronic Disease and College of Pharmacy, Sahmyook University)
Lee, Ki Man (Institute of Chronic Disease and College of Pharmacy, Sahmyook University) Lee, Geum Seon (Institute of Chronic Disease and College of Pharmacy, Sahmyook University) Seong, Ju-Won (Institute of Chronic Disease and College of Pharmacy, Sahmyook University) Kang, Tae Jin (Institute of Chronic Disease and College of Pharmacy, Sahmyook University) |
1 | Bellahsene, A. and Forsgren, A. (1980) Effect of rifampin on the immune response in mice. Infect. Immun. 27, 15-20. |
2 | Bergmann, R. L., Edenharter, G., Bergmann, K. E., Forster, J., Bauer, C. P., Wahn, V., Zepp, F. and Wahn, U. (1998) Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin. Exp.Allergy 28, 965-970. DOI |
3 | Bochenek, G. E., Nizankowska, E., Gielicz, A., Swierczynska, M. and Szczeklik, A. (2004) Plasma metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax 59, 459-464. DOI |
4 | Chang, T. S. and Shiung, Y. Y. (2006) Anti-IgE as a mast cell-stabilizing therapeutic agent. J. Allergy Clin. Immunol. 117, 1203-1212. DOI |
5 | Chung, T. H., Kang, T. J., Cho, W. K., Im, G. Y., Lee, G. S., Yang, M. C., Cho, C. W. and Ma, J. Y. (2012) Effectiveness of the novel herbal medicine, KIOM-MA, and its bioconversion product, KIOM-MA128, on the treatment of atopic dermatitis. Evid. Based Complement. Alternat. Med. 2012, 762918. |
6 | di Mauro, E., Synder, L., Marino, P., Lamberti, A., Coppo, A. and Tocchini-Valentini, G. P. (1969) Rifampicin sensitivity of the components of DNA-dependent RNA polymerase. Nature 222, 533-537. DOI |
7 | Eisenhut, M. and Wallace, H. (2011) Ion channels in inflammation. Pflugers Arch. 461, 401-421. DOI |
8 | Eule, H., Werner, E., Winsel, K. and Iwainsky, H. (1974) Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects. Tubercle 55, 81-89. DOI |
9 | Petersen, L. J., Mosbech, H. and Skov, P. S. (1996) Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. J. Allergy Clin. Immunol. 97, 672-679. DOI |
10 | Ashburn, T. T. and Thor, K. B. (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3, 673-683. DOI |
11 | Schwartz, L. B. and Austen, K. F. (1980) Enzymes of the mast cell granule. J. Invest. Dermatol. 74, 349-353. DOI |
12 | Lim, S. C., Lee, K. M. and Kang, T. J. (2015) Chitin from cuttlebone activates inflammatory cells to enhance the cell migration. Biomol. Ther. (Seoul) 23, 333-338. DOI |
13 | Wang, X., Grace, P. M., Pham, M. N., Cheng, K., Strand, K. A., Smith, C., Li, J., Watkins, L. R. and Yin, H. (2013) Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain. FASEB J. 27, 2713-2722. DOI |
14 | Wehrli, W., Knusel, F., Schmid, K. and Staehelin, M. (1968) Interaction of rifamycin with bacterial RNA polymerase. Proc. Natl. Acad. Sci. U.S.A. 61, 667-673. DOI |
15 | Ziglam, H. M., Daniels, I. and Finch, R. G. (2004) Immunomodulating activity of rifampicin. J. Chemother. 16, 357-361. DOI |
16 | Kwon, S. H., Ma, S. X., Ko, Y. H., Seo, J. Y., Lee, B. R., Lee, T. H., Kim, S. Y., Lee, S. Y. and Jang, C. G. (2016) Vaccinium bracteatum Thunb. exerts anti-inflammatory activity by inhibiting activation in BV-2 microglial cells. Biomol.Ther. (Seoul) 24, 543-551. DOI |
17 | Leung, D. Y., Boguniewicz, M., Howell, M. D., Nomura, I. and Hamid, Q. A. (2004) New insights into atopic dermatitis. J. Clin. Invest. 113, 651-657. DOI |
18 | Loeffler, A. M. (1999) Uses of rifampin for infections other than tuberculosis. Pediatr. Infect. Dis. J. 18, 631-632 DOI |
19 | Matsuda, H., Watanabe, N., Geba, G. P., Sperl, J., Tsudzuki, M., Hiroi, J., Matsumoto, M., Ushio, H., Saito, S., Askenase, P. W. and Ra, C. (1997) Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9, 461-466. DOI |
20 | Schwartz, L. B., Austen, K. F. and Wasserman, S. I. (1979) Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. J. Immunol. 123, 1445-1450. |
21 | Sidbury, R. and Hanifin, J. M. (2000) Systemic therapy of atopic dermatitis. Clin. Exp. Dermatol. 25, 559-566. DOI |
22 | Sleigh, S. H. and Barton, C. L. (2010) Repurposing strategies for therapeutics. Pharmaceut. Med. 24, 151-159. |
23 | Suto, H., Matsuda, H., Mitsuishi, K., Hira, K., Uchida, T., Unno, T., Ogawa, H. and Ra, C. (1999) NC/Nga mice: a mouse model for atopic dermatitis. Int. Arch. Allergy Immunol. 120 Suppl 1, 70-75. DOI |
24 | Tsai, M. J. and Saunders, G. F. (1973) Action of rifamycin derivatives on RNA polymerase of human leukemic lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 70, 2072-2076. DOI |
25 | Tsankov, N. and Angelova, I. (2003) Rifampin in dermatology. Clin. Dermatol. 21, 50-55. DOI |
26 | Tsudzuki, M., Watanabe, N., Wada, A., Nakane, Y., Hiroi, J. and Matsuda, H. (1997) Genetic analyses for dermatitis and IgE hyperproduction in the NC/Nga mouse. Immunogenetics 47, 88-90. DOI |
27 | Umeda, K., Noro, Y., Murakami, T., Tokime, K., Sugisaki, H., Yamanaka, K., Kurokawa, I., Kuno, K., Tsutsui, H., Nakanishi, K. and Mizutani, H. (2006) A novel acoustic evaluation system of scratching in mouse dermatitis: rapid and specific detection of invisibly rapid scratch in an atopic dermatitis model mouse. Life Sci. 79, 2144-2150. DOI |
28 | Nilsson, B. S. (1971) Rifampicin: an immunosuppressant? Lancet 2, 374. |
29 | Wang, W., Zhou, Q., Liu, L. and Zou, K. (2012) Anti-allergic activity of emodin on IgE-mediated activation in RBL-2H3 cells. Pharmacol. Rep. 64, 1216-1222. DOI |
30 | Mlambo, G. and Sigola, L. B. (2003) Rifampicin and dexamethasone have similar effects on macrophage phagocytosis of zymosan, but differ in their effects on nitrite and TNF- production. Int. Immunopharmacol. 3, 513-522. DOI |
31 | Park, J. Y., Lim, M. S., Kim, S. I., Lee, H. J., Kim, S. S., Kwon, Y. S. and Chun, W. (2016) Quercetin-3-O--D-glucuronide suppresses lipopolysaccharide-induced JNK and ERK phosphorylation in LPS-challenged RAW264.7 cells. Biomol. Ther. (Seoul) 24, 610-615. DOI |
32 | Paunescu, E. (1970) In vivo and in vitro suppression of humoral and cellular immunological response by rifampicin. Nature 228, 1188-1190. DOI |
33 | Pearce, F. L. (1985) Calcium and mast cell activation. Br. J. Clin. Pharmacol. 20, 267S-274S. DOI |
34 | Jung, J. W., Kim, S. J., Ahn, E. M., Oh, S. R., Lee, H. J., Jeong, J. A. and Lee, J. Y. (2014) Ribes fasciculatum var. chinense attenuated allergic inflammation in vivo and in vitro. Biomol. Ther. (Seoul) 22, 547-552. DOI |
35 | Fournier, T., Fadok, V. and Henson, P. M. (1997) Tumor necrosis factor- inversely regulates prostaglandin and prostaglandin production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase-2 expression and prostaglandin synthesis. J. Biol. Chem. 272, 31065-31072. DOI |
36 | Furue, M., Terao, H., Rikihisa, W., Urabe, K., Kinukawa, N., Nose, Y. and Koga, T. (2003) Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br. J. Dermatol. 148, 128-133. DOI |
37 | Gordon, J. R., Burd, P. R. and Galli, S. J. (1990) Mast cells as a source of multifunctional cytokines. Immunol. Today 11, 458-464. DOI |
38 | Kalesnikoff, J. and Galli, S. J. (2008) New developments in mast cell biology. Nat. Immunol. 9, 1215-1223. DOI |
39 | Kim, S. J., Jeong, H. J., Choi, I. Y., Lee, K. M., Park, R. K., Hong, S. H. and Kim, H. M. (2005) Cyclooxygenase-2 inhibitor SC-236 [4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-l] benzenesulfonamide] suppresses nuclear factor-kappaB activation and phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and c-Jun N-terminal kinase in human mast cell line cells. J. Pharmacol. Exp. Ther. 314, 27-34. DOI |
40 | Kim, S. K., Kim, Y. M., Yeum, C. E., Jin, S. H., Chae, G. T. and Lee, S. B. (2009) Rifampicin inhibits the LPS-induced expression of Toll-like receptor 2 via the suppression of DNA-binding activity in RAW 264.7 Cells. Korean J. Physiol. Pharmacol. 13, 475-482. DOI |